TB-500 plays crucial roles in cellular migration, tissue remodeling, and inflammation resolution
Gurtner GC, Werner S, Barrandon Y, Longaker MT
A consultation will help determine which specific peptides best support your goals
PMID: 33711021 Keywords Alpha Sympathomimetics Brimonidine Trade Names: Alphagan-P, Qoliana, Lumify & generic FDA approved in 1996 Drug Class: Alpha-2 Selective Adrenergic Agonist, Antiglaucoma, Vascular decongestant Mechanism of Action: 2 adrenoreceptor agonist approximately 10-times more selective for alpha-2 receptors compared to clonidine (Cambridge, 1981) does not exhibit significant tachyphylaxis with repeated use (Lee & Kim, 2022) Indications: Prescription & OTC to treat symptoms of: open-angle glaucoma : to lower intraocular pressure or ocular hypertension (Alphagan-P, Qoliana )
However, their effect may be particularly dose-dependent and more research is needed before specific recommendations can be made
Oxidative damage is attributed to diseases such as: Lou Gerhigs Disease (ALS), Parkinsons disease Autism Multiple Sclerosis Alzheimers Dementia Huntingtons Disease Cardiovascular Disease Chronic Fatigue Syndrome Cancer Diabetes Macular Degeneration Aging Liver Disease Skin Disorders Lung Disease ETC
